Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Police break up illegal chicken slaughter in Germany - 2Electric Vehicles for Eco-Accommodating Driving
- 3Why this Tennessee special election has the 'whole world' watching
- 4Some are walking out. Some are shouting. Some are oblivious. How kids are reacting to THAT 'Wicked: For Good' scene
- 5Pedal Power: Divulging Well known Bike Brands for Each Cyclist
- Figure out How to Recognize Early Indications of Depressions
- Discussion on deployment of foreign troops ongoing, two sources tell 'Post'
- Figure out How to Assess the Unwavering quality of SUVs for Seniors
- Man triggers smoke bomb during failed crypto robbery
- Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
- Cyclone causes blackout, flight chaos in Brazil's Sao Paulo
- Schools to start reopening after Nigeria mass abduction
- Deadly attack on kindergarten reported in Sudan
- 3 back-to-back storms forecast to bring snow and surges of cold air across the Midwest to the Northeast
